(Date:7/25/2008)... - 180-Days of Marketing Exclusivity Begin...l/ -- Watson,Pharmaceuticals, Inc. (NYSE: WPI ), ...ced today that its subsidiary has commenced commer...psules USP product in the 40mg,strength from its D...on,with the launch, Watson has 180 days of marketi...
(Date:7/25/2008)...AUMBURG, Ill., July 25 /PRNewswire/ -- Sagent Phar...maceutical company, today announced that it,has la...antiarrhythmic,indicated for the treatment and pro...llation and hemodynamically unstable ventricular,t...ular heart beat.,Sagent,s amiodarone HCl injection...
(Date:7/25/2008)...LSBAD, Calif., July 25 /PRNewswire/ -- AutoGenomic...ration statement on Form S-1 with the,Securities a...itial public,offering of shares of its common stoc...red, all of which are expected to be offered by,Au...ring, have not yet been,determined., J.P. Morgan ...
(Date:7/25/2008)... New program delivers immediate ... [24-hour telephone access to language interprete...ing multilingual solutions. , ... LLE® http://www.lle-inc.com/index.html [(L...ovider of interpretation, translation, and languag...
Breaking Medicine News(10 mins):Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3(Date:7/24/2008)...re/ -- Headlines claiming "soy,products lower sper...ale,preliminary study that Dr. Jorge Chavarro, pu...recollected intake of soyfoods and not on,specific...ded by many,issues, thus I feel the results should...r. Tammy Hedlund, a researcher in prostate cancer,...
(Date:7/24/2008)... -- MacroChem Corporation (OTC,Bulletin Board: MAC...rial,involving 37 patients who completed a 48-week...y study of EcoNail, a topical antifungal,lacquer f...he composite,primary efficacy endpoint of the tria... (negative fungal culture and negative KOH) and cl...
(Date:7/23/2008)...y print edition of Clinical C... /- A Roche Diagnostics-sponsored,pil...pe natriuretic peptide,(NT-proBNP) confirms the po... in predicting the risk of cardiovascular adverse ...dal anti-inflammatory drugs of,the COX inhibitor c...
(Date:7/23/2008)...arma Inc., a company developing,breakthrough molec...graphy,(PET) market, announced positive Phase I re...cer for myocardial perfusion imaging. BFPET is,Flu...ete Phase I clinical,development., BFPET is a PET...in the,heart (myocardial perfusion). Myocardial pe...
Breaking Medicine Technology:Soyfoods Do Not Impact Sperm Count 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3Rheumatoid Arthritis Treatment Guidelines Updated 22828 1Rheumatoid Arthritis Treatment Guidelines Updated 22828 2Rheumatoid Arthritis Treatment Guidelines Updated 22828 3First Nursing Facility Installation of Masimo Patient SafetyNet 28TM 29 Goes Live With Remarkable Results 22825 1First Nursing Facility Installation of Masimo Patient SafetyNet 28TM 29 Goes Live With Remarkable Results 22825 2First Nursing Facility Installation of Masimo Patient SafetyNet 28TM 29 Goes Live With Remarkable Results 22825 3First Nursing Facility Installation of Masimo Patient SafetyNet 28TM 29 Goes Live With Remarkable Results 22825 4First Nursing Facility Installation of Masimo Patient SafetyNet 28TM 29 Goes Live With Remarkable Results 22825 5American Airlines Miles for the Cure Campaign Raises More Than 24600 000 for Susan G Komen for the Cure 28R 29 22822 1American Airlines Miles for the Cure Campaign Raises More Than 24600 000 for Susan G Komen for the Cure 28R 29 22822 2American Airlines Miles for the Cure Campaign Raises More Than 24600 000 for Susan G Komen for the Cure 28R 29 22822 3First CyberKnife System to be Installed in Canada 22819 1First CyberKnife System to be Installed in Canada 22819 2First CyberKnife System to be Installed in Canada 22819 3First CyberKnife System to be Installed in Canada 22819 4...ort Rationale for Targeting Pro-Inflammatory,Prote...e-FirstCall/ --,MedImmune, Inc. today announced th...ing a role for high mobility group box,protein-1 (...ology,of systemic autoimmune diseases such as syst...toid arthritis. Data to be,published in the May 20...
...pril 19, 2007 /PRNewswire-FirstCall/ --,VioQuest P...aceutical company focused on acquiring, developing...nounced data from its,preclinical studies of VQD- ...treatment of solid and hematologic tumors.,Pre-cli...2007,Annual Meeting of the American Association fo...
Other Medicine Technology:MedImmune Publishes New Data in Nature Immunology Demonstrating The,Role HMGB1 May Play in Systemic Autoimmune Diseases 2MedImmune Publishes New Data in Nature Immunology Demonstrating The,Role HMGB1 May Play in Systemic Autoimmune Diseases 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 2VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 4VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 5Stat Fax 2600 is fully automatic microplate washer.
The Microtech Microplate Washer (220 V) is a flexible and ultra compact microplate washer. The system offers a wide choice of washing functions and sequences designed to handle most any microplate ap
PW 41 is a powerful, compact and programmable 2 x 8-channel microplate washers/aspirators, with built-in vacuum and dispensing pumps. Dispense and aspirate head heights ,are user-adjustable, with v
LHW is a solid made, manual plate washer for low throughput use. Separate valves for dispense and aspirate function ensure proper washing results. LHW8 comes complete with a stand and all necessary t
Medicine Products: